KDM6B and acute myeloid leukemia: In acute myeloid leukemia (AML), particularly the M2 and M3 subtypes, KDM6B overexpression reduces the number of leukemia stem cells, promotes bone marrow differentiation, and induces cellular senescence by upregulating the expression of C/EBPβ and its target genes (143).